Pages that link to "Q43036080"
Jump to navigation
Jump to search
The following pages link to A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C. (Q43036080):
Displaying 50 items.
- Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C (Q24201588) (← links)
- Ribavirin plus interferon versus interferon for chronic hepatitis C (Q24240879) (← links)
- Ribavirin plus interferon versus interferon for chronic hepatitis C (Q24244070) (← links)
- Retreatment of hepatitis C non-responsive to interferon. A placebo controlled randomized trial of ribavirin monotherapy versus combination therapy with Ribavirin and Interferon in 121 patients in the Benelux [ISRCTN53821378] (Q24805127) (← links)
- Hepatitis C virus: Promising discoveries and new treatments (Q27468916) (← links)
- De novo initiation of RNA synthesis by the RNA-dependent RNA polymerase (NS5B) of hepatitis C virus (Q27469625) (← links)
- Structure-Based Mutational Analysis of the Hepatitis C Virus NS3 Helicase (Q27469958) (← links)
- A peptide derived from RNA recognition motif 2 of human la protein binds to hepatitis C virus internal ribosome entry site, prevents ribosomal assembly, and inhibits internal initiation of translation (Q27470332) (← links)
- Combination thymosin alpha 1 and lymphoblastoid interferon treatment in chronic hepatitis C. (Q27473018) (← links)
- Clinical guidelines on the management of hepatitis C (Q27477946) (← links)
- A rational approach to the management of hepatitis C infection (Q27485902) (← links)
- (Q27486937) (← links)
- Interferon therapy for chronic hepatitis C. (Q30425525) (← links)
- WITHDRAWN: Ribavirin with or without alpha interferon for chronic hepatitis C. (Q33291074) (← links)
- Efficacy and tolerability of combination therapy with interferon-alfa plus ribavirin in patients with chronic hepatitis C virus infection: a single-center study in relapsers and nonresponders to previous treatment with high-dose interferon-alfa mono (Q33739046) (← links)
- New treatment strategies in non-responder patients with chronic hepatitis C. (Q33809555) (← links)
- Treatment of chronic hepatitis C in special groups (Q33809581) (← links)
- Mutations in carboxy-terminal part of E2 including PKR/eIF2alpha phosphorylation homology domain and interferon sensitivity determining region of nonstructural 5A of hepatitis C virus 1b: their correlation with response to interferon monotherapy and (Q33866399) (← links)
- Pathogenesis, diagnosis and management of hepatitis C. (Q33870245) (← links)
- Current therapy for chronic hepatitis C. (Q33951473) (← links)
- Treatment of chronic hepatitis C: impact of combination therapy (Q34027571) (← links)
- Combination treatment with interferon and ribavirin for chronic hepatitis C. (Q34210708) (← links)
- Effect of interferon and ribavirin combined with amantadine in interferon and ribavirin non-responder patients with chronic hepatitis C (genotype 1). (Q34605831) (← links)
- Management of viral hepatitis C. (Q34631375) (← links)
- Meta-analysis: combination therapy with interferon-alpha 2a/2b and ribavirin for patients with chronic hepatitis C previously non-responsive to interferon (Q34799386) (← links)
- Meta-analysis: ribavirin-induced haemolytic anaemia in patients with chronic hepatitis C. (Q34799396) (← links)
- Ribavirin uptake by human erythrocytes and the involvement of nitrobenzylthioinosine-sensitive (es)-nucleoside transporters (Q35027450) (← links)
- Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C. (Q35041900) (← links)
- Potassium Dehydroandrographolide Succinate Injection for the treatment of child epidemic parotitis: A systematic review and meta-analysis (Q35505366) (← links)
- Ribavirin and interferon alfa-2b in chronic hepatitis C: assessment of possible pharmacokinetic and pharmacodynamic interactions (Q35802787) (← links)
- Chronic hepatitis C and no response to antiviral therapy: potential current and future therapeutic options. (Q35824821) (← links)
- Treatment of acute and chronic hepatitis C. (Q35960898) (← links)
- Treatment of HCV: approach to difficult cases (Q35960907) (← links)
- Therapy of hepatitis C: from empiricism to eradication (Q36382235) (← links)
- Response of TT virus to IFN plus ribavirin treatment in patients with chronic hepatitis C (Q36474563) (← links)
- Combination of "low-dose" ribavirin and interferon alfa-2a therapy followed by interferon alfa-2a monotherapy in chronic HCV-infected non-responders and relapsers after interferon alfa-2a monotherapy (Q36491967) (← links)
- New treatment strategies against hepatitis C viral infection (Q36655935) (← links)
- Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C. Meta-analysis of individual patient data from European centers. (Q36865888) (← links)
- Predictors of early treatment discontinuation and severe anemia in a Brazilian cohort of hepatitis C patients treated with first-generation protease inhibitors. (Q37050953) (← links)
- Interferons and their use in persistent viral infections (Q37338989) (← links)
- Ribavirin mode of action in chronic hepatitis C: from clinical use back to molecular mechanisms (Q37340946) (← links)
- Pharmacotherapy of chronic hepatitis C virus infection - the IDEAL trial: '2b or not 2b (= 2a), that is the question'. (Q37627878) (← links)
- The role of ribavirin in direct acting antiviral drug regimens for chronic hepatitis C. (Q37972769) (← links)
- Boceprevir and personalized medicine in hepatitis C virus infection (Q38066185) (← links)
- What is the future of ribavirin therapy for hepatitis C? (Q38182243) (← links)
- Potassium dehydroandrographolide succinate injection for treat- ment of infantile pneumonia: a systematic review and Meta-analysis. (Q38389987) (← links)
- Pharmacokinetics and absolute bioavailability of ribavirin in healthy volunteers as determined by stable-isotope methodology. (Q39471947) (← links)
- Alpha interferon treatment of chronic hepatitis C (Q40466498) (← links)
- Evolution of hepatitis C virus genome in chronically infected patients receiving ribavirin monotherapy (Q40605824) (← links)
- Support for patients with hepatitis C: an exploratory qualitative study of medical specialists' perceptions (Q40813429) (← links)